Association of the Priority Review Voucher With Neglected Tropical Disease Drug and Vaccine Development

JAMA. 2017 Jul 25;318(4):388-389. doi: 10.1001/jama.2017.7467.


This study uses commercial pharmaceutical database data to evaluate the number of new drugs and vaccines for neglected tropical diseases entering phase 1 clinical trials before and after introduction in 2007 of a priority review voucher program to incentivize development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Trials, Phase I as Topic / statistics & numerical data
  • Drug Industry
  • Financing, Government
  • Humans
  • Orphan Drug Production / legislation & jurisprudence
  • Orphan Drug Production / statistics & numerical data*
  • Tropical Medicine*
  • United States